Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT ...

Going live on social media and enhancing customer experience are two practical strategies that will not only increase revenue ...

Blueprint Medicines Corporation, a Delaware-based biopharmaceutical company, recently released its financial results for the year ended December 31, 2024, along with key business highlights. The ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

In honor of Black History Month, I spoke with six Black women founders about how they’ve transformed resistance into ...

Blueprint Medicines (BPMC) sees strong AYVAKIT growth, 2025 revenue guidance at $680M-$710M. Discover insights on their market expansion & $2B 2030 vision.

The European Union’s executive has heeded the call of activist agricultural organizations and the complaints of hard-right ...

Hormone hazards can hide in everything from cosmetics to cleaning products. Here's how to avoid endocrine disruptors!

Astonishingly slim yet perfectly potent and with impressive camera capabilities, the Oppo Find N5 is the new foldable to beat ...

This concealer is the best I've tried so far. My skin is textured and tends to be dry in the colder months, so I appreciate ...